Palaamon Crowdfunding

Palaamon Crowdfunding

Created using Figma
To produce new innovative drugs, the pharmaceutical industry employs hundreds of thousands of Data Science experts.
How do these experts spend their time?
80% at installing and configuring computers, software and libraries
Can Data Science results be reproduced easily?
NO! Most complex analysis workflows are impossible to reproduce

Palaamon is a platform that streamlines and speeds the process of analyzing complex datasets using cutting-edge containerization and distributed ledger technologies.

Palaamon's technology finally solves the thorny problem of reproducibility, crucial for Pharmaceutical Research and Development.

Until now original research has been difficult to reproduce, and thus verify, because any variation in the original technical configuration can negatively affect reproducibility over time.

Palaamon enables full transparency, immutability, and reproducibility, no matter the user's technical setup.
10 jan. 2020
9 jul. 2020
100% voltooid
Opgehaald geld - geen gegevens
past
Details token
Ticker
PALCFT
Geaccepteerde valuta's
ETH
Bedrijfsgegevens
Geregistreerd land
Switzerland
aanvullende details
Categorieën
Platform

Over Palaamon Crowdfunding

Palaamon is a high-performance computing environment that distributes data analysis workflows across a cluster of computers, for highly scalable, virtually immutable and fully replicable results.

Palaamon enables researchers to reproduce workflows of analysis using well-tagged module containers. It traces all events of an analysis and records them to a distributed ledger. Every worker container, the code it runs, and all its dependencies are stored in Palaamon's registry to ensure ultimate reproducibility.

Palaamon is developed as a pure Reactive application using state-of-art technologies. Palaamon uses cryptographic hash functions at every level of processing to guarantee final traceability and reproducibility of workflows. Users of Palaamon are able to compare results of transforms based on similarity scores of Merkle trees. Palaamon provides a service to push results signatures to distributed ledgers.

Palaamon includes a marketplace that allows any developer, statistician, or data scientist to publish her code in any coding language to the platform and get rewarded in tokens when researchers license that algorithm. Coders and researchers mutually set the terms of use, which are then enshrined in smart contacts on the distributed ledger.

% naam% Roadmap

  • 2017

  • Palaamon Proof of Concept completed.
  • 2018

  • Palaamon Proof of Value completed on extended RNASeq data analysis workflow.
  • Q2 2019

  • Palaamon open source alpha v1.0 released.
  • Q3 2019

  • First official Palaamon's White Paper.
  • Lees verder
  • Q4 2019

  • Launching crowdfunding token PALCFT.
  • Q1 2020

  • Palaamon v1.0 beta released for UAT.
  • Q2 2020

  • PALCFT token crowdfunding ends.
  • Q3 2020

  • Palaamon Marketplace for Data Science Coders and Data scientists.
  • Q4 2020

  • First release of full fledged Palaamon SDK for data Science Coders.
  • Q1 2021

  • Scale-up of Palaamon to thousands of nodes.

Palaamon Crowdfunding Team

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Bernard Deffarges
CEO & Founder
geverifieerde
Damien Hauser
Founder
geverifieerde
Suzanne Studinger
Quality Assurance Lead
geverifieerde
Randy Baron
Software Engineer
geverifieerde
  • Omdat er mogelijk tijdsverschillen zijn in informatie-updates, moet nauwkeurige informatie over elk ICO-project worden geverifieerd via de officiële website of andere communicatiekanalen.
  • Deze informatie is geen suggestie of advies over beleggen in ICO-financiering. Onderzoek de relevante informatie zelf grondig en besluit over ICO-deelname.
  • Als u denkt dat er problemen of problemen zijn die moeten worden gecorrigeerd voor deze inhoud, of als u uw eigen ICO-project wilt indienen dat wordt vermeld, e-mail ons.
Lees de disclaimer en risicowaarschuwing. Laat disclaimer en risicowaarschuwing zien.